Accuray Inc ARAY

NAS: ARAY | ISIN: US0043971052   20:11
1,585 USD (-2,76%)
(-2,76%)   20:11

1 mei 2024 · Accuray Reports Fiscal 2024 Third Quarter Financial Results · Persbericht

25 april 2024 · Accuray Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024 · Persbericht

18 april 2024 · Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, Switzerland · Persbericht

17 april 2024 · Accuray to Report Third Quarter Fiscal 2024 Financial Results on May 1, 2024 · Persbericht

26 maart 2024 · New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife® System · Persbericht

4 maart 2024 · Accuray Incorporated to Speak at 36th Annual Roth Conference · Persbericht

27 februari 2024 · Accuray Incorporated to Speak at Oppenheimer 34th Annual Healthcare MedTech & Services Conference · Persbericht

13 februari 2024 · Quebec Cancer Center is First in Canada to Treat Cancer Patients Using the Accuray Radixact® System · Persbericht

5 februari 2024 · Accuray to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference · Persbericht

31 januari 2024 · Accuray Reports Fiscal 2024 Second Quarter Financial Results · Persbericht

25 januari 2024 · Providence Swedish Radiosurgery Center in Seattle Invests in Second Accuray CyberKnife® System, a Robotic Delivery Device That Makes Extremely Precise Radiation Treatments Possible in 1-5 Sessions · Persbericht

16 januari 2024 · Accuray to Report Second Quarter Fiscal 2024 Financial Results on January 31, 2024 · Persbericht

5 december 2023 · Accuray Initiates Sales of the VitalHold™ Solution in Japan, Supporting Surface-guided Radiation Therapy on the Radixact® System · Persbericht

7 november 2023 · Accuray Reports Fiscal 2024 First Quarter Financial Results · Persbericht

31 oktober 2023 · Accuray to Participate in the 14th Annual Jefferies London Healthcare Conference · Persbericht

26 oktober 2023 · Accuray to Report First Quarter Fiscal 2024 Financial Results on November 7, 2023 · Persbericht

3 oktober 2023 · Accuray Announces Approval of the Tomo® C Radiation Treatment Delivery System by China's National Medical Products Administration · Persbericht

2 oktober 2023 · Accuray and Limbus AI Unveil Online Adaptive Therapy Solution for the Radixact® System at American Society for Radiation Oncology (ASTRO) Annual Meeting · Persbericht

18 september 2023 · Accuray Opens New Global Training Center at Madison, WI Headquarters to Advance Radiotherapy Treatment Techniques Amid Growing Demand for Precision Cancer Care · Persbericht

14 september 2023 · Accuray to Host Investor Day at ASTRO on October 3, 2023 · Persbericht

Mijn selecties